Neonatal Lymphatic Flow Disorder.
Chylothorax
Lymphatic flow disorder
Newborn
Journal
Indian journal of pediatrics
ISSN: 0973-7693
Titre abrégé: Indian J Pediatr
Pays: India
ID NLM: 0417442
Informations de publication
Date de publication:
11 Apr 2023
11 Apr 2023
Historique:
received:
06
10
2022
accepted:
21
02
2023
entrez:
11
4
2023
pubmed:
12
4
2023
medline:
12
4
2023
Statut:
aheadofprint
Résumé
To examine and discuss patients diagnosed with acquired and congenital chylothorax in the neonatal period in the light of the literature. The files of newborns followed-up in the neonatal intensive care unit (NICU) and diagnosed with congenital and acquired chylothorax were reviewed retrospectively. Patients with isolated chylothorax were classified as Group 1 and those with multiple lymphatic flow disorders were classified as Group 2. Antenatal and clinical features were recorded and compared between the groups. Thirteen infants were diagnosed with chylothorax; 92.3% (n = 12) of the patients were congenital. The rate of antenatal diagnosis was 61.5% (n = 8). Eight patients (61.5%) were diagnosed with hydrops fetalis. Among the cases in Group 1 and Group 2, receiving ocreotide and the incidence of sepsis (p = 0.05) were partially significant. Seven of the patients (66.6%) responded to medium chain triglycerides (MCT), and complete resolution was seen in 6 (85.7%) of the responders. Complete resolution of chylothorax fluid was observed in 7 (77.7%) of nine patients who responded to ocreotide treatment. In neonatal chylothorax, the postnatal period includes a multidisciplinary approach that requires drug therapy, dietary modifications, drainage of pleural fluid, and rarely, surgery.
Identifiants
pubmed: 37040015
doi: 10.1007/s12098-023-04531-x
pii: 10.1007/s12098-023-04531-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Dr. K C Chaudhuri Foundation.
Références
Attar MA, Donn SM. Congenital chylothorax. Semin Fetal Neonatal Med. 2017;22:234–9.
doi: 10.1016/j.siny.2017.03.005
pubmed: 28351595
Das A, Shah PS. Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst Rev. 2010;CD006388. https://doi.org/10.1002/14651858.CD006388.pub2 .
Bellini C, Ergaz Z, Boccardo F, et al. Dynamics of pleural fluid effusion and chylothorax in the fetus and newborn: role of the lymphatic system. Lymphology. 2013;46:75–84.
pubmed: 24354106
Krishnamurthy MB, Malhotra A. Congenital chylothorax: current perspectives and trends. Res Rep Neonatol. 2017;7:53–63.
Büttiker V, Fanconi S, Burger R. Chylothorax in children: guidelines for diagnosis and management. Chest. 1999;116:682–7.
doi: 10.1378/chest.116.3.682
pubmed: 10492271
Bellini C, Cabano R, Bellini T, Boccardo F, Morcaldi G, Ramenghi LA. Congenital chylothorax of the newborn: diagnosis and treatment in three pictures. Lymphology. 2016;49:150–6.
pubmed: 29906078
Bialkowski A, Poets CF, Franz AR; Erhebungseinheit für seltene pädiatrische Erkrankungen in Deutschland Study Group. Congenital chylothorax: a prospective nationwide epidemiological study in Germany. Arch Dis Child Fetal Neonatal Ed. 2015;100:F169–72.
doi: 10.1136/archdischild-2014-307274
pubmed: 25480460
Dorsi M, Giuseppi A, Lesage F, et al. Prenatal factors associated with neonatal survival of infants with congenital chylothorax. J Perinatol. 2018;38:31–4.
doi: 10.1038/jp.2017.150
pubmed: 29048403
Levine C. Primary disorders of the lymphatic vessels – a unified concept. J Pediatr Surg. 1989;24:233–40.
doi: 10.1016/S0022-3468(89)80001-6
pubmed: 2709285
Costa KM, Saxena AK. Surgical chylothorax in neonates: management and outcomes. World J Pediatr. 2018;14:110–5.
doi: 10.1007/s12519-018-0134-x
pubmed: 29508361
White MK, Bhat R, Greenough A. Neonatal chylothoraces: a 10-year experience in a Tertiary Neonatal Referral Centre. Case Rep Pediatr. 2019;2019:3903598.
Mosby. Mosby’s medical, nursing and allied health dictionary. In: Anderson K, Aderson LE, Glanze WD, editors. 4th ed. Maryland Heights: Mosby; 1994. p. 335.
Le Nué R, Molinaro F, Gomes-Ferreira C, et al. Surgical management of congenital chylothorax in children. Eur J Pediatr Surg. 2010;20:307–11.
doi: 10.1055/s-0030-1254164
pubmed: 20577953
Bellini C, Cabano R, De Angelis LC, et al. Octreotide for congenital and acquired chylothorax in newborns: a systematic review. J Paediatr Child Health. 2018;54:840–7.
doi: 10.1111/jpc.13889
pubmed: 29602276
Malleske DT, Yoder BA. Congenital chylothorax treated with oral sildenafil: a case report and review of the literature. J Perinatol. 2015;35:384–6.
doi: 10.1038/jp.2015.10
pubmed: 25917021
Mitchell K, Weiner A, Ramsay P, Sahni M. Use of propranolol in the treatment of chylous effusions in infants. Pediatrics. 2021;148:e2020049699.
doi: 10.1542/peds.2020-049699
pubmed: 34187907
Kugelman A, Gonen R, Bader D. Potential role of high-frequency ventilation in the treatment of severe congenital pleural effusion. Pediatr Pulmonol. 2000;29:404–8.
doi: 10.1002/(SICI)1099-0496(200005)29:5<404::AID-PPUL11>3.0.CO;2-4
pubmed: 10790254
Scottoni F, Fusaro F, Conforti A, Morini F, Bagolan P. Pleurodesis with povidone-iodine for refractory chylothorax in newborns: personal experience and literature review. J Pediatr Surg. 2015;50:1722–5.
doi: 10.1016/j.jpedsurg.2015.03.069
pubmed: 25969129
Bernet-Buettiker V, Waldvogel K, Cannizzaro V, Albisetti M. Antithrombin activity in children with chylothorax. Eur J Cardiothorac Surg. 2006;29:406–9.
pubmed: 16439146
Hoskote AU, Ramaiah RN, Cale CM, Hartley JC, Brown KL. Role of immunoglobulin supplementation for secondary immunodeficiency associated with chylothorax after pediatric cardiothoracic surgery. Pediatr Crit Care Med. 2012;13:535–41.
doi: 10.1097/PCC.0b013e318241793d
pubmed: 22760424
McMullan DM. Should intravenous immunoglobulin be given to patients with postoperative chylothorax? Pediatr Crit Care Med. 2012;13:599–600.
doi: 10.1097/PCC.0b013e31824ea2e6
pubmed: 22955461